---
schema_version: "secwatch.filing_event.v1"
accession: "0002007919-26-000050"
form_type: "8-K"
ticker: "INBX"
cik: "0002007919"
company_name: "Inhibrx Biosciences, Inc."
filed_at: "2026-09-28T21:03:44+00:00"
generated_at: "2026-10-12T13:37:33.928096+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Inhibrx Biosciences posts updated investor presentation to website; exhibit text truncated with no new data disclosed

## Summary
- Inhibrx Biosciences (INBX) said it posted an updated corporate presentation to the 'Investors' tab of www.inhibrx.com on September 28, 2026.
- The 8-K provides no financial results, guidance, clinical data or deal terms; only the presentation's title slide and forward-looking-statements disclaimer are included in the filing text.
- Filing signed by Chief Financial Officer Kelly Deck, dated September 28, 2026; company is a Delaware corporation headquartered at 11025 N. Torrey Pines Road, La Jolla, CA.
- Because the exhibit content is not readable here, no specific updates to pipeline, cash runway or trial timelines can be confirmed.

## SEC filing metadata
- accession: 0002007919-26-000050
- form_type: 8-K
- ticker: INBX
- cik: 0002007919
- company_name: Inhibrx Biosciences, Inc.
- filed_at: 2026-09-28T21:03:44+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2007919/000200791926000050/0002007919-26-000050-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2007919/000200791926000050/inhibrx-20260928.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0002007919-26-000050
- JSON: https://secwatch.observer/filing/0002007919-26-000050.json
- Plain text: https://secwatch.observer/filing/0002007919-26-000050.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.